Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.
Levine
G N
GN
Evans Memorial Department of Medicine, Boston University School of Medicine, MA.
Keaney
J F
JF
Vita
J A
JA
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000401:mortality; D002986:Clinical Trials as Topic; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D009017:Morbidity; D009569:Nitric Oxide / Q000502:physiology
D000924:Anticholesteremic Agents; D009569:Nitric Oxide